Risk-reducing salpingo-oophorectomy (RRSO) can substantially reduce ovarian cancer incidence in women carrying pathogenic BRCA1 or BRCA2 variants, which cause hereditary breast and ovarian cancer syndrome. The gene discussed is BRCA2; the disease is ovarian cancer.